Logo MSM

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo MSM Logo MSM Logo MSM

31 December 1969

Changes in serum PICP concentrations during therapy with growth hormone in children with chronic renal failure

Maria Sieniawska, Małgorzata Pańczyk-Tomaszewska, Beata Leszczyńska, Maria Roszkowska-Blaim

Med Sci Monit 1998; 4(6): CR960-965 :: ID: 451732

Abstract

The aim of the study was to evaluate serum PICP level (carboxyterminal propeptide of type I procollagen) during the treatment with recombinant human growth hormone (rhGH) of short-stature children with chronic renal failure (CRF). The work was also an attempt to establish whether PICP level during the first months of therapy had a predictive value concerning faster growth in this group of children. The study included 36 children. Group I consisted of 17 subjects aged 10.3±2.6 years treated with continuous ambulatory peritoneal dialysis (CAPD), group II was made up of 9 children on haemodialysis (HD), aged 12.5±2.1 years, while group III was formed of 10 children with pre-end-stage renal failure (PESRF), aged 10±3.3 years. All the patients received 1.1 u/kg/week subcutaneous rhGH every evening for 12 months. Serum PICP level was determined before starting rhGH treatment as well as in 1, 3, 6, 9 and 12 month of therapy. Patients' growth was measured with stadiometer every 3 months.
Results: Mean growth (DH) after 12 months of treatment was: 7.98±2.04 cm in group I, 7.37±1.9 cm in group II, 8.25±2.47 cm in group III. The highest mean PICP level was observed in 6th month of treatment (423.7±148.7 µg/l), p=0.001 in relation to mean PICP value before the beginning of therapy. There was a stronger positive correlation between PICP concentration in 1st month (r=0.5, p < 0.01) than between PICP level in 3rd and 6th month of treatment and DH after 1 year of rhGH therapy. However, we found low PICP levels in 1st month of therapy in children with satisfactory DH, i.e. over 7cm/year as well as in those with insufficient DH, i. e. below 6 cm/year.
Conclusions: 1. Mean PICP level increases during the first 6 months of treatment with rhGH. 2. PICP concentration in the first month of therapy correlates with growth acceleration in the first year of rhGH administration, but it is of no prognostic value for individual patients.

Keywords: PICP, chronic renal failure, Growth Hormone

0 Comments

This Week Editorial

13 September 2021 : Editorial

Editorial: The First Monoclonal Antibody Vaccine to Prevent Malaria Heralds a New Era of Malaria Vaccines to the Plasmodium falciparum Circumsporozoite Protein (PfCSP)

Dinah V. Parums
Science Editor, Medical Science Monitor, International Scientific Information, Inc., Melville, NY, USA

DOI: 10.12659/MSM.934676

Med Sci Monit 2021; 27:e934676

Coronavirus/Covid 19

15 September 2021 : Editorial

Editorial: Autoantibodies to Components of the Immune System, Including Type 1 Interferons, and the Risk of...

Med Sci Monit In Press; DOI: 10.12659/MSM.934766  

08 September 2021 : Clinical Research

Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...

Med Sci Monit In Press; DOI: 10.12659/MSM.932788  

16 July 2021 : Review article

Silent Hypoxemia in Patients with COVID-19 Pneumonia: A Review

Med Sci Monit In Press; DOI: 10.12659/MSM.930776  

09 July 2021 : Database Analysis

A Simple Clinical Prediction Tool for COVID-19 in Primary Care with Epidemiology: Temperature-Leukocytes-CT...

Med Sci Monit In Press; DOI: 10.12659/MSM.931467  

In Press

16 Sep 2021 : Clinical Research

A Retrospective Evaluation of Operative and Postoperative Outcomes in Patients with Spinal Metastases from ...

Med Sci Monit In Press; DOI: 10.12659/MSM.932995  

15 Sep 2021 : Clinical Research

Polish Medical Air Rescue Interventions Concerning Pregnant Women in Poland: A 10-year Retrospective Analysis

Med Sci Monit In Press; DOI: 10.12659/MSM.933029  

15 Sep 2021 : Editorial

Editorial: Autoantibodies to Components of the Immune System, Including Type 1 Interferons, and the Risk of...

Med Sci Monit In Press; DOI: 10.12659/MSM.934766  

15 Sep 2021 : Clinical Research

A Prospective Single-Center Study of the Effects of Repetitive Transcranial Magnetic Stimulation at 2-Week ...

Med Sci Monit In Press; DOI: 10.12659/MSM.933017  

Most Viewed

20 Mar 2020 : Clinical Research

Social Capital and Sleep Quality in Individuals Who Self-Isolated for 14 Days During the Coronavirus Diseas...

DOI :10.12659/MSM.923921

Med Sci Monit 2020; 26:e923921

15 Apr 2020 : Clinical Research

Psychological Impact and Coping Strategies of Frontline Medical Staff in Hunan Between January and March 20...

DOI :10.12659/MSM.924171

Med Sci Monit 2020; 26:e924171

05 May 2020 : Review article

An Evidence Based Perspective on mRNA-SARS-CoV-2 Vaccine Development

DOI :10.12659/MSM.924700

Med Sci Monit 2020; 26:e924700

26 Apr 2020 : Clinical Research

Comparison of Prevalence and Associated Factors of Anxiety and Depression Among People Affected by versus P...

DOI :10.12659/MSM.924609

Med Sci Monit 2020; 26:e924609

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750